1222 DEMONBREUN STREET, NASHVILLE, TN
Market cap: $381.0M (2/05/2025)
Price: $3.65
Announces Completion of Acquisition of Revance Therapeutics
Amend the A&R Merger Agreement to Increase Offer Price to $3.65 per Share and Extend Existing Tender Offer
News, Reorganization Plan
Enter into Amended and Restated Merger Agreement
Twelfth Waiver to Agreement and Plan of Merger
Eleventh Waiver to Agreement and Plan of Merger
Tenth Waiver to Agreement and Plan of Merger
Other Events
Q3
Q2
Q1
FY 2023
FY 2022
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
S-8 POS